Source: BIOPORTFOLIO

ASCEND: Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

Quebecbased biopharma drug developer Aeterna Zentaris has said it is to collaborate with womens healthcare specialist Ascend Therapeutics on the copromotion of two products.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Nicholas Hart's photo - President & CEO of ASCEND Therapeutics

President & CEO

Nicholas Hart

CEO Approval Rating

81/100

Read more